Status:
COMPLETED
TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care
Lead Sponsor:
Fonds de la Recherche en Santé du Québec
Collaborating Sponsors:
Université de Montréal
Conditions:
Diabetes Mellitus, Type 2
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The TRANSIT program is a program to TRANSform InTerprofessional clinical practices to improve cardiovascular prevention in primary care. It addresses priorities in primary care relevant to the Chronic...
Detailed Description
STUDY DESIGN: Pragmatic cluster randomized clinical trial SETTING: Nine Family Medicine Groups (FMGs) take part in the study. FMGs are primary care clinics delivering family medicine services. They...
Eligibility Criteria
Inclusion
- patient is registered in a Family Medicine Group;
- 10-year Framingham risk score (FRS) moderate (11-19%) to high (≥ 20%);
- at least one of the following condition uncontrolled:
- Diabetes: HbA1C \> 7% OR fasting blood glucose \> 7 mmol/L OR 2-hour postprandial blood glucose \> 10 mmol/L (OR \> 8 mmol/L if HbA1C target is not acheived)(Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Journal of Diabetes, 2008)
- Dyslipidemia: C-LDL ≥ 2 mmol/L in moderate to high risk patients OR less than 50% reduction of C-LDL compared to initial value OR Apo-B ≥ 0,8 g/L (Genest, McPherson et al. 2009)
- Hypertension: blood pressure ≥ 140/90 ou ≥ 130/80 in diabetic patients or with chronic kidney disease (TFG \< 60mL/min/1,73m2; (Cloutier \& Poirier 2011)
- Patient with at least two chronic disease or chronic health problem other than type II diabetes, dyslipidemia, hypertension, or cardiovascular disease (e.g. : angina, previous history of myocard infarct, stroke, and intermittent claudication).
Exclusion
- Patient followed for a cardiovascular disease in a specialized clinic in secondary care (ex.: cardiology, endocrinology etc).
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
759 Patients enrolled
Trial Details
Trial ID
NCT01418716
Start Date
April 1 2011
End Date
October 1 2016
Last Update
February 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de santé et de services sociaux de Laval
Laval, Quebec, Canada, H7M 3L9